Ingevity (NGVT) Set to Post Quarterly Earnings on Wednesday

Ingevity (NYSE:NGVT) is anticipated to release its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to announce earnings of $1.56 per share and revenue of $303.91 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 10:00 AM ET.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.41. The firm had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. On average, analysts expect Ingevity to post $5.40 EPS for the current fiscal year and $5.90 EPS for the next fiscal year.

Ingevity Stock Performance

NYSE:NGVT opened at $75.21 on Wednesday. Ingevity has a 52-week low of $45.85 and a 52-week high of $79.29. The stock’s 50 day moving average price is $70.26 and its 200 day moving average price is $71.01.

Insider Buying and Selling

In other Ingevity news, CEO David Li sold 5,000 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total transaction of $379,150.00. Following the sale, the chief executive officer directly owned 120,636 shares in the company, valued at approximately $9,147,827.88. The trade was a 3.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan Fisher sold 2,709 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the sale, the senior vice president owned 15,722 shares in the company, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 17,801 shares of company stock worth $1,347,481 in the last ninety days. 0.88% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

NGVT has been the topic of a number of recent research reports. Weiss Ratings cut shares of Ingevity from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Ingevity currently has an average rating of “Hold” and a consensus price target of $80.00.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, efficiency, and sustainability across a range of industrial and consumer applications. Its offerings serve markets including automotive, transportation, agriculture, coatings, adhesives, pavement markings, and industrial manufacturing.

The company is best known for activated carbon products used in automotive vapor-emission control systems, where they help capture fuel vapors and reduce emissions.